[Therapeutic progresses of hepatitis C].
Ma
Qiao-yu
QY
Institute of Infectious Diseases, Southwest Hospital, Third Military Medicial University, Chongqing 400038, China.
D000998:Antiviral Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects; D012254:Ribavirin / Q000008:administration & dosage*; D016896:Treatment Outcome
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin